Prospective Evaluation of Radiotherapy Using Magnetic Resonance Image Guided Treatment

Last updated: November 6, 2019
Sponsor: Institute of Cancer Research, United Kingdom
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cancer

Treatment

N/A

Clinical Study ID

NCT03727698
CCR4841
  • Ages > 5
  • All Genders

Study Summary

The purpose of PERMIT is to collect information on the treatment of radiotherapy patients using a new radiotherapy machine that includes magnetic Resonance (MR) imaging (MR linac) to guide treatment. The aim is to use this information to support the introduction of MR Linac into clinical practice.

PERMIT will collect details on patients treated on the MR linac plus details on their side effects and other outcomes. This information plus technical and imaging information will be combined with information from other centres using this machine. By doing so this will help us learn how best to use the MR Linac in the future and design new radiotherapy protocols

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Radiotherapy treatment suitable to be delivered on the MR Linac.

  2. Patient provides written, informed consent and/or authorization.

  3. Patients between the ages of 5 and under 16 years old may enter protocol withparental/guardian consent.

Exclusion

Exclusion Criteria:

  1. Contra-indications to MR imaging.

  2. Radiotherapy not suitable for delivery on the MR Linac e.g. those with extended fieldlengths (exceeding 20 cm).

Study Design

Total Participants: 200
Study Start date:
January 11, 2019
Estimated Completion Date:
November 30, 2025

Connect with a study center

  • Royal Marsden NHSFT

    London,
    United Kingdom

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.